National Healthcare Corp

NHC remains in a Stage 2 advancing regime with medium-term bullish structure intact, but price is extended above rising EMAs and has printed a Bullish Exhaustion candle in extreme overbought conditions. Short-term timing is unfavorable for immediate entry; defer participation and stalk for a pullback into the rising EMA support zone.

• ↑Acquired 35 facilities for $560M, adding assets accretive to earnings and cash flow.
• ↑Strong earnings yield at 1.13 and robust profitability support debt servicing.
• ↓Acquisition added $475M debt, elevating interest costs and leverage risk.